Munson Gillian has reported an acquisition of additional shares in Phreesia, Inc., a company specializing in healthcare technology. This transaction is significant as it demonstrates Gillian's confidence in the company's future and the broader healthcare technology sector.

Background

Munson Gillian is a director at Phreesia, Inc., which operates under the Central Index Key (CIK) number 0001412408. The company is classified under the services-business services category. Recent filings show that Gillian has been actively involved in the management and growth of Phreesia, with multiple Form 4 filings indicating ongoing transactions.

What the Filing Says

According to the recent filing dated November 2, 2026, Gillian acquired 502 shares of Phreesia common stock on October 30, 2026, at a price of $12.44 per share. Following this transaction, Gillian now owns a total of 67,291 shares. The filing notes, "Granted as a result of director's election to receive deferred stock units (DSUs) in lieu of an annual cash retainer..." This indicates a strategic choice to convert cash compensation into stock ownership, aligning her interests with the company’s performance.

Impact

This acquisition may affect various stakeholders, including Phreesia's management, employees, and shareholders. Gillian's increased ownership could signal to other investors a strong belief in Phreesia's potential for growth, possibly influencing their investment decisions. Additionally, her role as a director means her actions may inspire confidence among other board members and stakeholders in the company's direction.

What's Next

The filing does not say what happens next.